本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kura Oncology, Inc

11.39
-0.1800-1.56%
盤後11.520.1300+1.14%19:40 EDT
成交量:211.75萬
成交額:2,424.42萬
市值:10.11億
市盈率:-3.38
高:11.75
開:11.58
低:11.34
收:11.57
52周最高:13.90
52周最低:7.36
股本:8,877.44萬
流通股本:7,060.22萬
量比:1.27
換手率:3.00%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
淨資產收益率:-167.71%
總資產收益率:-31.30%
市淨率:20.88
市盈率(LYR):-3.58

資料載入中...

2026/09/09

重要事件披露

Form 8-K - Current report
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/30

重要事件披露

Form 8-K - Current report
2026/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]